Skip to main content

Table 2 Tumor multiplicities/incidences in NNK-treated A-C/EBP- or A-C/EBP+ mice fed Dox or regular diet at 52 weeks post-NNK administration for additional 10 weeks and analyzed at 62 weeks post-NNK administration

From: Deficiency of CCAAT/enhancer binding protein family DNA binding prevents malignant conversion of adenoma to carcinoma in NNK-induced lung carcinogenesis in the mouse

Group

Genotype (A-C/EBP

Treatment

Diet during

No. of mice

Body weight

Gross tumor

 

Histological

lesions

 

Tumor incidence

 

+ or -a)

 

52-62 weeks

examined

(g)

per mouse

Alveolar hyperplasia per mouse

Adenoma per mouse

Carcinoma per mouse

Adenoma and carcinoma per mouse

(%)b

1

-

NNK

Dox

19

42.2±1.4d

2.00

0.37

1.63

0.37e

2.00

95 (17)c

2

+

NNK

Dox

18

44.5±1.5d

2.83

0.33

2.06

0.056f

2.11

83 (15)

3

-

NNK

Regular

18

36.2±1.6

1.89

0.11

1.50

0.44

1.94

94 (16)

4

+

NNK

Regular

18

38.1±1.6

2.22

0.17

2.00

0.44

2.44

78 (14)

  1. aA-C/EBP- is considered as wild-type control.
  2. bPercentage of mice with adenomas or carcinomas.
  3. cNumbers in parentheses show the number of mice having tumors.
  4. dSignificantly different from their respective regular diet group (group 1 vs. 3, 2 vs. 4) at P<0.01 by student t-test.
  5. eSignificantly different from their respective A-C/EBP+ group (group 1 vs. 2) at P<0.05 by student t-test.
  6. fSignificantly different from their respective regular diet group (group 2 vs. 4) at P<0.05 by student t-test.